MEET OUR EXTERNAL COUNCIL MEMBERS AND SITE ALLIANCE CHAMPIONS
We founded an External Council for Advancing Inclusive Research® with leading experts who are partnering with us to develop solutions to reduce barriers to clinical study participation and define the next era of inclusive research.
Additionally, through our Advancing Inclusive Research (AIR) Site Alliance, we are prioritizing inclusive research to increase patient representation in clinical studies.
External Council Members
Meet the External Council Members
AIR Site Alliance Champions
Meet the Site Alliance ChampionsExternal Council
The External Council for Advancing Inclusive Research is composed of physician thought leaders, academic researchers, and patient advocates with expertise in oncology, ophthalmology and neuroscience clinical care, research and genomics.
Otis Brawley
MD, MACP, FRCP (L), FASCO, FACE
Bloomberg Distinguished Professor, Johns Hopkins University
John Carpten
PhD
Director of City of Hope Comprehensive Cancer Center; Director of Beckman Research Institute of City of Hope, and Chief Scientific Officer
Keith D. Carter
MD, FACS
Chairman and Head, Department of Ophthalmology, University of Iowa; Past President of the American Academy of Ophthalmology
Joseph Coney
MD, FASRS
Ophthalmologist & Retinal Specialist, Retina Associates of Cleveland, Case Western Reserve and University Hospital
Andrea Ferris
MBA
President & Chief Executive Officer, LUNGevity Foundation
Owen Garrick
MD, MBA
Dean of Clinical Trials, Mayo Clinic
Edward S. Kim
MD, MBA FACP, FASCO
Physician-in-Chief and Senior Vice President, City of Hope Orange County, and Vice Physician-in-Chief, City of Hope National Medical Center
Ruben A. Mesa
MD, FACP
Enterprise Senior Vice President, Atrium Health, and Vice Dean for Cancer Programs, Wake Forest University School of Medicine
Edith Mitchell
MD, MACP, FCCP, FRCP (L)
Enterprise Vice President for Cancer Disparities, Sidney Kimmel Cancer Center
In Memoriam; Genentech is grateful for Dr. Mitchell's commitment to advance inclusive research and health equity and as a founding member of the External Council for Advancing Inclusive Research.
Stephanie Monroe
JD
Executive Director, UsAgainstAlzheimer’s African American Network
Edith Perez
MD
Professor Emeritus, Mayo Clinic
Fabian Sandoval
MD
President & Chief Executive Officer, Emerson Clinical Research Institute
Mitzi Joi Williams
MD, FAAN
Neurologist & MS Specialist, Joi Life Wellness Group, Department of Neurology, Emory University
Robert Winn
MD
Director NCI Cancer Center, Virginia Commonwealth University, Massey Cancer Center
Quita Highsmith
MBA
Vice President and Chief Diversity Officer, Genentech
Karsten Jung
PhD, MBA
Head of Global Product Strategy, Co-Chair, Advancing Inclusive Research, Roche Pharmaceuticals
Toby Patterson
MD
Senior Vice President and Head, US Medical Affairs, Co-Chair, Advancing Inclusive Research, Genentech
Nicole Richie
PhD
VP, Global Head Health Equity & Population Science, Co-Lead, Advancing Inclusive Research, Genentech
Veronica Sandoval
PhD, JD
Principal, Patient Inclusion & Health Equity, Chief Diversity Office, Genentech
Pierre Theodore
MD
Executive Director, Patient Inclusion & Health Equity, Chief Diversity Office, Genentech
Gerren Wilson
PharmD
Lifecycle Leader, Respiratory & Allergy Franchise, Roche
Advancing Inclusive Research Site Alliance Champions
The U.S. Advancing Inclusive Research Site Alliance is a coalition of clinical research sites in oncology and ophthalmology that partner with Genentech to advance the representation of diverse patient populations in the company’s clinical trials, test recruitment and retention approaches, and establish best practices that can be leveraged across the industry to help achieve health equity.
Jeremiah Brown, Jr.
MS, MD
Vitreoretinal Surgeon, Retina Consultants of Texas / Brown Retina Institute
Bassel El-Rayes
MD
Deputy Director of O’Neal Comprehensive Cancer Center at UAB and Director of the Division of Hematology and Oncology
Oana Danciu
MD
UICC Associate Director of Clinical Research
Balazs Halmos
MD, MS
Associate Director for Clinical Science, Director, Thoracic Oncology, Director, Precision Medicine, Professor of Clinical Medicine, Montefiore Einstein Comprehensive Cancer Center
Alex Herrera
MD
Associate Professor, Chief, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Stephen Huddleston
MD
Vitreoretinal Surgeon, Charles Retina Institute
Kapil Kapoor
MD, FACS, FICS, FASRS
Ophthalmologist and Eye Surgeon, President of Research, Wagner Kapoor Institute
Supreet Kaur
MD
Assistant Professor, Mays Cancer Center, UT San Antonio
Daruka Mahadevan
MD, PhD
Division Chief, Hematology/Medical Oncology, Director of the Institute of Drug Development, Mays Cancer Center, UT San Antonio
Amelie Ramirez
Dr.PH
Chair and Professor of the Department of Population Health Sciences, Director of the Institute for Health Promotion Research, Director of the Salud America program, Associate Director of Cancer Outreach and Engagement at Mays Cancer Center at UT Health San Antonio
Barry Sleckman
MD, PhD
Director, O'Neal Comprehensive Cancer Center at University of Alabama, Birmingham
Gregory Vidal
MD, PhD
Director of Clinical Research, Lead, Breast Cancer Division, OneOncology, West Cancer Center, Associate Professor University of Tennessee Health Science Center
Alan Wagner
MD, FACS, FICS,FASRS, AME
Founder, Ophthalmologist, and Eye Surgeon, Wagner Kapoor Institute
Ruma Bhagat
MD, MPH
Principal Science Leader, Global Health Equity & Population Sciences, Genentech
Meghan McKenzie
MA
Principal, Patient Inclusion & Health Equity, Chief Diversity Office, Genentech